Answers are grounded in this paper and cite their sources.
5‑Aminolevulinic acid‑mediated photodynamic therapy (ALA‑PDT) is a minimally invasive therapeutic modality used in the management of various cancers, but to a lesser extent for esophageal cancer (EC). The current study investigated the antitumor effects of ALA‑PDT. Human EC cells were treated with ALA, after which ALA‑induced fluorescence was examined under a fluorescence microscope. The cytotoxic effects of ALA‑PDT were assessed using three types of LEDs (blue, green and red) in vitro and in vivo. Subcutaneous tumor model mice was constructed with KYSE150 cells. ALA‑PDT was performed once a week for 4 weeks and tumor weights were measured. A popliteal lymph node (PLN) metastasis murine model was generated using KYSE150 cells. KYSE150 cells were inoculated into the left footpad of nude mice. ALA‑PDT was performed on the footpad once a week for 4 weeks. PLNs were then removed 3 weeks after the last treatment. The lymph nodes were evaluated by hematoxylin and eosin staining. Red fluorescence of protoporphyrin IX (PpIX) was observed in all EC cell lines. ALA‑PDT using LEDs exerted significant antitumor effects in vitro and in vivo. The antitumor effects of ALA‑PDT with blue LED were the strongest, followed by green and red LEDs. The number of metastasized PLNs was significantly smaller in the ALA‑PDT group (0%) than in the control group (37.5%). The present results indicated that ALA‑PDT is effective for EC.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: